Cite

    Richard J Vickers et al.. “Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.” Lancet infectious diseases, vol. 17, no. 7, n.d., pp. 735–744. http://access.bl.uk/ark:/81055/vdc_100151540277.0x000007